These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutation. Carr R, Cataland SR. Ann Hematol; 2013 Jun; 92(6):845-6. PubMed ID: 23154867 [No Abstract] [Full Text] [Related]
8. Successful discontinuation of eculizumab therapy in a patient with aHUS. Pu JJ, Sido A. Ann Hematol; 2014 Aug; 93(8):1423-5. PubMed ID: 24346709 [No Abstract] [Full Text] [Related]
9. [HTA-pre-eclampsia-postpartum haemolytic-uraemic syndrome: good results can be achieved]. Santos Nores J, Bravo López JJ, Borrajo Prol MP, Iglesias Forneiro A. Nefrologia; 2010 Aug; 30(5):593-4. PubMed ID: 20882100 [No Abstract] [Full Text] [Related]
10. Cryptic activity of atypical hemolytic uremic syndrome and eculizumab treatment. Belingheri M, Possenti I, Tel F, Paglialonga F, Testa S, Salardi S, Ardissino G. Pediatrics; 2014 Jun; 133(6):e1769-71. PubMed ID: 24843058 [Abstract] [Full Text] [Related]